![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 ACTAVIS GROUP PTC EHF (1)
02 AUROBINDO PHARMA ITALIA Srl (1)
03 Actavis Group PTC ehf (1)
04 HIKMA FARMACEUTICA S.A. (1)
05 HOSPIRA ITALIA Srl (1)
06 Hospira UK Limited (1)
07 MSD ITALIA Srl (1)
08 Merck Sharp & Dohme B.V. (1)
09 Orifarm AS (1)
10 RANBAXY ITALIA SpA (1)
01 Imipenem (4)
02 Imipenem; Cilastatin (6)
01 Imipenem+Cilastatin+500500 Mg 1 Unit Parenteral Use (1)
02 Imipenem+Cilastatin+500500 Mg 10 Units Parenteral Use (2)
03 Imipenem+Cilastatin+500500 Mg 20Ml 1 Units Parenteral Use (1)
04 Imipenem+Cilastatin+500500 Mg 20Ml 5 Units Parenteral Use (1)
05 Imipenem+Cilastatin+500500 Mg 30Ml 1 Units Parenteral Use (1)
06 Powder for infusion fluid, resolution (4)
01 Italy (6)
02 Norway (4)
01 Imecitin (1)
02 Imipenem And Cilastatin (3)
03 Imipenem Cilastatin (1)
04 Imipenem/Cilastatin Actavis (1)
05 Imipenem/Cilastatin Hospira (1)
06 Tienam (3)